CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs.

Saved in:

Bibliographic Details
Title:	CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs.
Authors:	Vandervorst F; Department of Neurology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium., Van Deun L; Department of Neurology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium., Van Dycke A; Department of Neurology, General Hospital Sint-Jan Bruges, Bruges, Belgium., Paemeleire K; Department of Neurology, Ghent University Hospital, Ghent, Belgium., Reuter U; Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany., Schoenen J; Headache Research Unit, Dept of Neurology-Citadelle Hospital, University of Liège, Liège, Belgium., Versijpt J; Department of Neurology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium. jan.versijpt@uzbrussel.be.
Source:	The journal of headache and pain [J Headache Pain] 2021 Oct 25; Vol. 22 (1), pp. 128. Date of Electronic Publication: 2021 Oct 25.
Publication Type:	Journal Article
Journal Info:	Publisher: BioMed Central Country of Publication: England NLM ID: 100940562 Publication Model: Electronic Cited Medium: Internet ISSN: 1129-2377 (Electronic) Linking ISSN: 11292369 NLM ISO Abbreviation: J Headache Pain Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1129-2377
DOI:	10.1186/s10194-021-01335-2